Management of Migraine Pain: Emerging Opportunities and Challenges

The book delves into the multifaceted world of migraine pain, offering a profound understanding of its underlying pathophysiology and presenting established treatment strategies for its effective management. It discusses the intricate world of migraine pain, offering valuable insights into its diverse aspects. Starting with an exploration of migraine's epidemiology and etiology and the complex factors contributing to this debilitating headache disorder. This book explores the significance of lifestyle changes and offers practical strategies for incorporation. Furthermore, the impact of diet and nutrients on migraine management is extensively covered, shedding light on their role in alleviating symptoms.

This book serves as a comprehensive guide, blending scientific insights with practical approaches, making it an indispensable resource for healthcare professionals, researchers, and individuals seeking a deeper understanding of migraine pain. By addressing both established practices and cutting-edge advancements, it bridges the gap between knowledge and effective management, offering a holistic perspective on this challenging condition.

Dr. Shvetank Bhatt is currently working as an associate professor in School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, Maharashtra, India. He has done M.Pharm in pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka and Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. He has total 16 years of industrial and academic research experience. His area of specialization is CNS disorders, pain, inflammation and immunooncology. He is recipient of Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Best Paper in Pharmacology-IJPER) in 2012 and 2014. He has published more than 80 papers and 20 book chapters. Dr. Bhatt is having total citation 1445; h- index 18 and i10- index 42. He is life member of Association of Pharmaceutical Teachers of India (APTI) and Indian Pharmacological Society (IPS).

Prof. (Dr.) CR Patil is working as a professor and head, Dept. of Pharmacology, R. C Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra. He has done M.Pharm in pharmacology from Gujarat University, Ahmedabad and PhD from Shivaji University Kolhapur. He has more than 24 years of teaching and research experience. His area of expertise is CVS Pharmacology, pain and inflammation. He is recipient of various awards including Innovator Teacher Award (2017), MHRD, Govt of India, New Delhi and Young Scientist Award (2017), CCRH-AYUSH, New Delhi. He has published more than 100 papers and book chapters. Dr. Patil is having total citation 4200; h- index 34 and i10- index 66.

Prof. (Dr.) Neeraj Mahindroo is medicinal chemist with experience of over 25 years in academics and research. Currently he is working as professor and dean at School of Health Sciences and Technology, MIT World Peace University, Pune, India. Earlier he was founder Dean of the School of Health Sciences and Technology, UPES, Dehradun. He was also the Dean of the Faculty of Pharmaceutical Sciences and Dean of Research & Development at Shoolini University. School of Pharmaceutical Sciences was ranked in the top 40 under the leadership for four consecutive years (2016 (19), 2017(39), 2018 (30), 2019 (39)) by the National Institutional Ranking Framework (NIRF), Ministry of HRD, Government of India. Member of University NIRF, NAAC, and NBA core team.

Experience in PCI and AICTE fillings and inspections. His research interests are drug discovery for neglected diseases, neurological disorders, and cancer, screening of fractionated extracts, and isolated compounds from plants from the North-Western Himalayas. Published 45 papers with more than 2194 citations (h index = 25; i10 index=36), five patents, and ten patent applications. He is Member of the Editorial Advisory Board of ACS Medicinal Chemistry Letters and member of CII National Committee on R&D & Innovation 2020-21, part of the Sub-group on Healthcare & Chemicals.